Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Instruments
2.1.1.1. Secondary Instrument
2.1.1.2. Primary Instrument
2.1.2. Research Approaches
2.1.2.1. Bottom-up Approach
2.1.2.2. Top-down Approach
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.1.5. Vendor Inclusion Criteria
2.2. Forecasting Methodology
2.2.1. Methodology for Market Estimation & Forecasting
2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
4. Premium Insight
4.1. Market Connectivity
4.2. Market Data Feed
4.3. Market Vendor Ranking Analysis
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.4.4. Challenges
4.5. Porter's Five Forces Analysis
4.5.1. Threat of New Entrants
4.5.2. Threat of Substitutes
4.5.3. Bargaining Power of Customers
4.5.4. Bargaining Power of Suppliers
4.5.5. Industry Rivalry
5. Global Radiopharmaceuticals Market, by Procedural Volume
5.1. Introduction
5.2. Alpha Emitters
5.3. Beta Emitters
5.4. Brachytherapy Isotopes
5.5. Pet Radiopharmaceuticals
5.6. Spect Radiopharmaceuticals
6. Global Radiopharmaceuticals Market, by Type
6.1. Introduction
6.2. Alpha Emitters
6.2.1. Ra-223
6.3. Beta Emitters
6.3.1. I-131
6.3.2. Lu-177
6.3.3. Re-186
6.3.4. Sm-153
6.3.5. Y-90
6.4. Brachytherapy Isotopes
6.4.1. Cs-131
6.4.2. I-125
6.4.3. Ir-192
6.4.4. Pd-103
6.5. Pet Radiopharmaceuticals
6.5.1. F-18
6.5.2. Ru-82
6.6. Spect Radiopharmaceuticals
6.6.1. Ga-67
6.6.2. I-123
6.6.3. Tc-99m
6.6.4. Tl-201
7. Global Radiopharmaceuticals Market, by Application
7.1. Introduction
7.2. Bone Metastasis
7.3. Cardiology
7.4. Endocrine Tumors
7.5. Lymphoma
7.6. Neurology
7.7. Oncology
7.8. Thyroid
8. Global Radiopharmaceuticals Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Cancer Research Institutes
8.4. Diagnostic Centers
8.5. Hospitals
9. Global Radiopharmaceuticals Market, by Geography
9.1. Introduction
9.2. Americas Radiopharmaceuticals Market
9.2.1. Americas Radiopharmaceuticals Market, by Country
9.2.1.1. United States
9.2.1.2. Brazil
9.2.1.3. Canada
9.2.1.4. Mexico
9.2.1.5. Argentina
9.2.2. Americas Radiopharmaceuticals Market, by Procedural Volume
9.2.3. Americas Radiopharmaceuticals Market, by Type
9.2.4. Americas Radiopharmaceuticals Market, by Application
9.2.5. Americas Radiopharmaceuticals Market, by End User
9.3. Europe, Middle East & Africa Radiopharmaceuticals Market
9.3.1. Europe, Middle East & Africa Radiopharmaceuticals Market, by Country
9.3.1.1. United Kingdom
9.3.1.2. Germany
9.3.1.3. France
9.3.1.4. Saudi Arabia
9.3.1.5. United Arab Emirates
9.3.1.6. Italy
9.3.1.7. Russia
9.3.2. Europe, Middle East & Africa Radiopharmaceuticals Market, by Procedural Volume
9.3.3. Europe, Middle East & Africa Radiopharmaceuticals Market, by Type
9.3.4. Europe, Middle East & Africa Radiopharmaceuticals Market, by Application
9.3.5. Europe, Middle East & Africa Radiopharmaceuticals Market, by End User
9.4. Asia-Pacific Radiopharmaceuticals Market
9.4.1. Asia-Pacific Radiopharmaceuticals Market, by Country
9.4.1.1. China
9.4.1.2. Japan
9.4.1.3. India
9.4.1.4. Australia
9.4.2. Asia-Pacific Radiopharmaceuticals Market, by Procedural Volume
9.4.3. Asia-Pacific Radiopharmaceuticals Market, by Type
9.4.4. Asia-Pacific Radiopharmaceuticals Market, by Application
9.4.5. Asia-Pacific Radiopharmaceuticals Market, by End User
10. 360iResearch Competitive Strategic Window
10.1. Introduction
10.1.1. Leverage Zone
10.1.2. Vantage Zone
10.1.3. Speculative Zone
10.1.4. Bottleneck Zone
11. 360iResearch FPNV Positioning Matrix
11.1. Introduction
11.2. 360iResearch Scores
11.2.1. Forefront
11.2.2. Pathfinders
11.2.3. Niche
11.2.4. Vital
11.3. Business Strategy
11.4. Product Satisfaction
12. Competitive News Feed Analysis
13. Company Usability Profiles
13.1. Advanced Accelerator Applications
13.2. Bayer
13.3. Bracco Imaging
13.4. Cardinal Health
13.5. Curium
13.6. Eckert & Ziegler
13.7. Eczacibasi-Monrol Nuclear Products
13.8. Ge Healthcare
13.9. IBA Radiopharma Solutions
13.10. Lantheus Medical Imaging
13.11. Mallinckrodt plc.
13.12. Nordion
13.13. Positron Corporation
13.14. Siemens Healthineers
14. Appendix
14.1. Top Reports
14.2. Author Details

LIST OF TABLES (49 TABLES)

TABLE 1. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 2. GLOBAL RADIOPHARMACEUTICALS MARKET RANKING, BY VENDORS, 2017
TABLE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2016 - 2024 (USD MILLION)
TABLE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 29. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 30. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2016 - 2024 (USD MILLION)
TABLE 31. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 32. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 33. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2016 - 2024 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 39. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 40. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2016 - 2024 (USD MILLION)
TABLE 41. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 42. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 43. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 44. 360IRESEARCH SCORES FOR FOREFRONT IN RADIOPHARMACEUTICALS MARKET
TABLE 45. 360IRESEARCH SCORES FOR PATHFINDERS IN RADIOPHARMACEUTICALS MARKET
TABLE 46. 360IRESEARCH SCORES FOR NICHE IN RADIOPHARMACEUTICALS MARKET
TABLE 47. 360IRESEARCH SCORES FOR VITAL IN RADIOPHARMACEUTICALS MARKET
TABLE 48. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR RADIOPHARMACEUTICALS MARKET
TABLE 49. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR RADIOPHARMACEUTICALS MARKET

LIST OF FIGURES (43 TABLES)

FIGURE 1. GLOBAL RADIOPHARMACEUTICALS MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL RADIOPHARMACEUTICALS MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL RADIOPHARMACEUTICALS MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL RADIOPHARMACEUTICALS MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL RADIOPHARMACEUTICALS MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL RADIOPHARMACEUTICALS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL RADIOPHARMACEUTICALS MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL RADIOPHARMACEUTICALS MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL RADIOPHARMACEUTICALS MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. RADIOPHARMACEUTICALS MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD MILLION)
FIGURE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2017 VS 2024 (USD MILLION)
FIGURE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2017 VS 2024 (USD MILLION)
FIGURE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2017 VS 2024 (USD MILLION)
FIGURE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2017 VS 2024 (USD MILLION)
FIGURE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 38. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET, BY PROCEDURAL VOLUME, 2024
FIGURE 39. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE, 2024
FIGURE 40. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2024
FIGURE 41. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET, BY END USER, 2024
FIGURE 42. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET, BY GEOGRAPHY, 2024
FIGURE 43. 360IRESEARCH FPNV POSITIONING MATRIX FOR RADIOPHARMACEUTICALS MARKET